Imetelstat (1) – Rytelo®

Myelodysplastic syndromes with transfusion-dependent anaemia, previously treated

Characteristics

Start date 15.11.2026
Resolution 05.05.2027 – active procedure
INN Imetelstat
Brand name Rytelo®
Pharm. company Geron Netherlands B.V.
G-BA Procedure ID D-1406
Therapeutic area Hematopoietic diseases Orphan
Reason for procedure Initial assessment

Associated procedures

Imetelstat (1) Rytelo® Geron Netherlands B.V. Hematopoietic diseases Myelodysplastic syndromes with transfusion-dependent anaemia, previously treated n.d. active procedure Orphan


<< List of all resolutions